喹啉酮
肌醇
激酶
化学
生物化学
计算生物学
医学
药理学
生物
立体化学
受体
作者
Tyler Heitmann,Gangling Liao,Pablo de León,Glen Ernst,Ingrid P. Buchler,Huijun Wei,Evgeny Shlevkov,Dean G. Brown,Martina Fitzek,Matthew Collier,David M. Smith,James C. Barrow
标识
DOI:10.1021/acsmedchemlett.3c00409
摘要
A high-throughput fragment-based screen has been employed to discover a series of quinazolinone inositol hexakisphosphate kinase (IP6K) inhibitors. IP6Ks have been studied for their role in glucose homeostasis, metabolic disease, fatty liver disease, chronic kidney disease, blood coagulation, neurological development, and psychiatric disease. IP6Ks phosphorylate inositol hexakisphosphate (IP6) to form pyrophosphate 5-diphospho-1,2,3,4,6-pentakisphosphate (IP7). Molecular docking studies and investigation of structure-activity relationships around the quinazolinone core resulted in compounds with submicromolar potency and interesting selectivity for IP6K1 versus the closely related IP6K2 and IP6K3 isoforms.
科研通智能强力驱动
Strongly Powered by AbleSci AI